Nanovaccine Shows Promising Animal Models at UTSW
Jinming Gao, Ph.D., Professor in the Harold C. Simmons Comprehensive Cancer Center and of Biomedical Engineering, Cell Biology, Otolaryngology – Head & Neck Surgery, and Pharmacology at UTSW UT Southwestern Medical Center scientists have developed a nanoparticle vaccine that successfully eradicated tumors in an animal model of late-stage, metastatic HPV-induced cancers, according to a study published in Proceedings of the National Academy of Sciences (PNAS). The breakthrough could pave the way for a new class of vaccines to treat a variety of cancers. Jinming Gao, Ph.D., professor at the Harold C. Simmons Comprehensive Cancer Center and of Biomedical Engineering at UT Southwestern states: “Our study provides a safe and effective way to treat cancers that have spread or cannot be surgically removed. Creating a nanovaccine for systemic use for metastatic cancers is not easy due to potential toxicity, but we have overcome those challenges with this new therapy.”
Nanovaccine Shows Promising Animal Models at UTSW
